Paape M J, Lilius E M, Wiitanen P A, Kontio M P, Miller R H
USDA-ARS, Immunology and Disease Resistance Laboratory, Beltsville, MD 20705, USA.
Am J Vet Res. 1996 Apr;57(4):477-82.
To examine Escherichia coli lipopolysaccharide (LPS) effects on expression of CD14 and CD18 cell surface receptors and lectin/carbohydrate-mediated nonopsonic phagocytosis of E coli.
Cell isolation, monoclonal antibody, phagocytosis, and flow cytometric studies.
4 clinically normal lactating Holstein cows for studies on CD14 and CD18, and 2 for phagocytosis studies.
Binding of CD14 and CD18 monoclonal antibodies to blood and milk neutrophils and mononuclear leukocytes was studied by flow cytometry before and after intramammary injection of LPS, and nonopsonic phagocytosis of E coli by blood neutrophils was determined. Presence of intracellular CD14 was determined after in vitro incubation of neutrophils in skimmed milk and after fixation and permeabilization of freshly isolated neutrophils.
Before LPS injection, percentages of blood neutrophils and large mononuclear (LMO) cells expressing CD14 averaged 3 and 63% and 68 and 35% for mammary neutrophils and LMO cells, respectively. After LPS injection, CD14 was only detected on blood and mammary LMO cells (61 and 25%); receptor expression increased by 1.8- and threefold, respectively. In vitro incubation of neutrophils in skimmed milk increased the percentage of neutrophils expressing CD14. The number of blood neutrophils staining positive for CD14 increased after permeabilization of the plasma membrane, which was blocked by unlabeled anti-CD14 monoclonal antibodies. Before LPS, percentages of blood neutrophils and LMO cells expressing CD18 averaged 93 and 95% and was 88 and 55% for mammary neutrophils and LMO cells, respectively. After LPS, percentages of mammary neutrophils and LMO cells expressing CD18 increased to 100 and 95%, respectively. Expression of CD18 was 2.6-fold higher for mammary neutrophils before injection of LPS, compared with blood neutrophils, either before or after LPS. In absence of opsonins, neutrophils with adherent and phagocytosed E coli averaged 83 and 14%.
LPS modulated expression of CD14 and CD18 and lectin-carbohydrate interactions mediated nonopsonic phagocytosis of E coli. An intracellular pool of CD14 exists in bovine neutrophils and is capable of translocating to the cell surface.
Development of methods to maximize expression of CD14 receptors on mammary neutrophils involved in production of tumor necrosis factor-alpha, and nonopsonic phagocytosis could result in reducing prevalence of mastitis in dairy cows.
研究大肠杆菌脂多糖(LPS)对CD14和CD18细胞表面受体表达以及凝集素/碳水化合物介导的大肠杆菌非调理吞噬作用的影响。
细胞分离、单克隆抗体、吞噬作用及流式细胞术研究。
4头临床正常的泌乳荷斯坦奶牛用于CD14和CD18研究,2头用于吞噬作用研究。
通过流式细胞术研究在乳腺内注射LPS前后,CD14和CD18单克隆抗体与血液和乳汁中的中性粒细胞及单核白细胞的结合情况,并测定血液中性粒细胞对大肠杆菌的非调理吞噬作用。在脱脂牛奶中体外培养中性粒细胞后,以及对新鲜分离的中性粒细胞进行固定和通透处理后,测定细胞内CD14的存在情况。
在注射LPS前,血液中性粒细胞和表达CD14的大单核(LMO)细胞的百分比平均分别为3%和63%,乳腺中性粒细胞和LMO细胞分别为68%和35%。注射LPS后,仅在血液和乳腺LMO细胞上检测到CD14(分别为61%和25%);受体表达分别增加了1.8倍和3倍。在脱脂牛奶中体外培养中性粒细胞增加了表达CD14的中性粒细胞百分比。质膜通透后,血液中CD14染色阳性的中性粒细胞数量增加,这被未标记的抗CD14单克隆抗体阻断。在注射LPS前,血液中性粒细胞和表达CD18的LMO细胞的百分比平均分别为93%和95%,乳腺中性粒细胞和LMO细胞分别为88%和55%。注射LPS后,表达CD18的乳腺中性粒细胞和LMO细胞的百分比分别增加到100%和95%。注射LPS前,乳腺中性粒细胞的CD18表达比血液中性粒细胞高2.6倍,无论在注射LPS之前还是之后。在没有调理素的情况下,附着并吞噬大肠杆菌的中性粒细胞平均分别为83%和14%。
LPS调节CD14和CD18的表达以及凝集素-碳水化合物相互作用介导的大肠杆菌非调理吞噬作用。牛中性粒细胞中存在细胞内CD14池,并且能够转运到细胞表面。
开发使参与肿瘤坏死因子-α产生的乳腺中性粒细胞上CD14受体表达最大化的方法,以及非调理吞噬作用可能会降低奶牛乳腺炎的患病率。